This is how CVS Caremark and GoodRx are robbing patients and pharmacies. Patient copay: $45.83 Drug cost: $23.86 CVS/GoodRx Fee: $38.50 Profit: (-$16.03) That's right, the PBM and GoodRx are charging the patient 192% of drug cost while charging the pharmacy 162% of the drug cost. The pharmacy keeps 30% of drug cost, a 70% loss and the patient pays an inflated fee. CVS Caremark is bouncing down these claims to GoodRx, without patient or pharmacy permission, and then the pharmacy is being charged outrageous fees. Pharmacies are forced to run these claims as cash to not take a huge loss, leaving the patient without money going toward their deductible. CVS Caremark wins if they get to charge the fee and Aetna wins if the patient doesn't have this count toward their deductible. The patient and the pharmacy lose. Price fixing and vertical integration at their finest. A marriage of greed despotism. And this for a schedule II medication that brings along with it more costs and risks than normal for the pharmacy. There is no incentive to even exist. @truthrx @linakhanFTC @matthewstoller @econliberties @SaraLSirota #Pharmacy #TwitteRx
